Evidence for population-based BRCA1 and BRCA2 screening for ovarian cancer prevention

被引：0
|
作者：
Levy-Lahad, E. [1 ]
Gabai-Kapara, E. [1 ]
Kaufman, B. [2 ]
Catane, R. [2 ]
Segev, S. [3 ]
Renbaum, P.
Beller, U. [4 ]
King, M. C. [5 ,6 ]
Lahad, A. [7 ]
机构：
[1] Hebrew Univ Jerusalem, Sch Med, Inst Med Genet, Shaare Zedek Med Ctr, IL-91010 Jerusalem, Israel
[2] Chaim Sheba Med Ctr, Div Oncol, IL-52621 Tel Hashomer, Israel
[3] Chaim Sheba Med Ctr, Inst Med Screening, IL-52621 Tel Hashomer, Israel
[4] Shaare Zedek Med Ctr, Dept Obstet & Gynecol, Jerusalem, Israel
[5] Univ Washington, Dept Med Med Genet, Seattle, WA 98195 USA
[6] Univ Washington, Dept Genome Sci, Seattle, WA 98195 USA
[7] Hebrew Univ Jerusalem, Sch Med, Dept Family Med, IL-91010 Jerusalem, Israel
来源：
INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER | 2012年 / 22卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：S43 / S43
页数：1
相关论文
共 50 条
  • [41] Should there be different ovarian cancer treatment strategies based on BRCA1 and BRCA2?
    Harrison, Natalie
    EXPERT REVIEW OF ANTICANCER THERAPY, 2011, 11 (12) : 1787 - 1787
  • [42] Should there be different ovarian cancer treatment strategies based on BRCA1 and BRCA2?
    Harrison, Natalie
    PHARMACOGENOMICS, 2011, 12 (12) : 1633 - 1634
  • [43] BRCAsearch - results of population-based screening of BRCA1 and BRCA2 germline mutations in incident breast cancer in South Sweden
    Loman, N.
    Borg, A.
    Henriksson, K.
    Kristoffersson, U.
    Kvist, A.
    Silfverberg, B.
    Toerngren, T.
    Brandberg, Y.
    Nilsson, M.
    CANCER RESEARCH, 2017, 77
  • [44] BRCA1 and BRCA2 alterations in ovarian MMMT
    Geisler, JP
    Goodheart, MJ
    Buller, RE
    GYNECOLOGIC ONCOLOGY, 2004, 95 (03) : 774 - 774
  • [45] The Role of Testing for BRCA1 and BRCA2 Mutations in Cancer Prevention
    McCarthy, Anne Marie
    Armstrong, Katrina
    JAMA INTERNAL MEDICINE, 2014, 174 (07) : 1023 - 1024
  • [46] Population-based screening of Uruguayan Ashkenazi Jews for recurrent BRCA1 and BRCA2 pathogenic sequence variants
    Castillo, Cecilia
    Camejo, Natalia
    Artagaveytia, Nora
    Brignoni, Lucia
    Laitman, Yael
    Cayota, Alfonso
    Krygier, Gabriel
    Delgado, Lucia
    Friedman, Eitan
    CANCER RESEARCH, 2024, 84 (09)
  • [47] Population-based screening of Uruguayan Ashkenazi Jews for recurrent BRCA1 and BRCA2 pathogenic sequence variants
    Castillo, Cecilia
    Artagaveytia, Nora
    Brignoni, Lucia
    Laitman, Yael
    Camejo, Natalia
    Hernandez, Ana Laura
    Krygier, Gabriel
    Cayota, Alfonso
    Delgado, Lucia
    Friedman, Eitan
    MOLECULAR GENETICS & GENOMIC MEDICINE, 2022, 10 (06):
  • [48] GLOBAL ECONOMIC EVALUATION OF POPULATION-BASED BRCA1/BRCA2 MUTATION TESTING
    Manchanda, R.
    Sun, L.
    Patel, S.
    Wilschut, J.
    Lopes Carolina de Freitas, A.
    Brentnall, A.
    Duffy, S.
    Cui, B.
    de Soarez Coelho, P.
    Husain, Z.
    Vanni, T.
    Hopper, J.
    Sadique, Z.
    Mukopadhyay, A.
    Yang, L.
    Berkof, H.
    Legood, R.
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2019, 29 : A6 - A7
  • [49] Screening BRCA1 and BRCA2 Mutation Carriers for Breast Cancer
    Warner, Ellen
    CANCERS, 2018, 10 (12)
  • [50] BRCA1 and BRCA2 cancer risks
    Antoniou, Antonis C.
    Pharoah, Paul D. P.
    Easton, Douglas F.
    Evans, D. Gareth
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (20) : 3312 - 3313
12345